Home / Stocks / AVLN

AVLN insider trading

Avalyn Pharma Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$25.0M
Buys · last 90 days
0 · $0
Most recent buy
2026-05-05

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-05Novo Holdings A/S
10% owner
Bought555,555$18.00$10.0M
2026-05-01Carroll Jill
Director
Bought277,778$18.00$5.0M
2026-05-01George Simeon
10% owner
Bought555,555$18.00$10.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Novo Holdings A/S10% owner1$10.0M
George Simeon10% owner1$10.0M
Carroll JillDirector1$5.0M

See AVLN on the chart

Every insider buy and sell for AVLN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.